Header Logo

Connection

Megan Lerner to Receptor, Fibroblast Growth Factor, Type 2

This is a "connection" page, showing publications Megan Lerner has written about Receptor, Fibroblast Growth Factor, Type 2.
  1. Oncolytic potential of a novel KGFR tyrosine kinase inhibitor using a KGFR-selective breast cancer xenograft model. Anticancer Res. 2015 Jan; 35(1):47-52.
    View in: PubMed
    Score: 0.119
  2. Influence of KGF on the progression of pancreatic cancer. Anticancer Res. 2009 Aug; 29(8):3417-20.
    View in: PubMed
    Score: 0.020
  3. Antisense KGFR oligonucleotide inhibition of KGF-induced motility in breast cancer cells. Anticancer Res. 2003 Nov-Dec; 23(6C):4913-9.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.